Incidence of anti-COVID-19 IgM and IgG in asymptomatic gastroenterological care workers

Withdrawn

• Conditions: Corona virus; COVID-19; 10047438

• Registration Number: NL-OMON50117
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

People working at the endoscopy department of the Erasmus Medical Center can
only be included.
They have been working at the endoscopy department in the last two weeks.

Exclusion Criteria

Not working (anymore) at the endoscopy department

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Number of workers with a positive COVID-19 finger prick blood test for IgM<br /><br>and/or IgG antibodies. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- Number of subjects developing COVID-19 IgM and/or IgG antibodies during the<br /><br>study period<br /><br>- Number of subjects with physical complaints and a positive finger prick test<br /><br>- Number of subjects with physical complaints and a negative finger prick test</p><br>